S&N rebrands wound care buy; Stent overuse linked to deaths;

@FierceMedDev: EU committee backs tougher, U.S.-style device approval system. Article | Follow @FierceMedDev

@MarkHFierce: FierceDiagnostics has another great crop of stories. Check it out | Follow @MarkHFierce

@MichaelGFierce: Study: Artificial pancreas with inhaled insulin improves glucose control. Story from FierceDrugDelivery | Follow @MichaelGFierce

> Smith & Nephew ($SNN) snatched up Healthpoint Biotherapeutics nearly a year ago, and now it will change its name to Smith & Nephew Biotherapeutics. Item

> Deaths from the use of cardiac stents are rising, with some connecting the trend to their overuse. Story

> AdvaMed 2013 concluded in Washington, D.C. having attracted nearly 2,100 people from 30 countries, the trade group said. Item

> Vertebral Technologies in Minneapolis gained a 510(k) clearance for its new modular lateral lumbar interbody fusion device. Item

> A Japanese robotics firm will invest in Israel's ARGO Medical Technologies, which is developing a robotic device that helps paralyzed patients walk. Story

Biotech News

@FierceBiotech: Eli Lilly will eventually have to come to grips with the fact that its R&D strategy and execution has been woeful. Story | Follow @FierceBiotech

@JohnCFierce: IPO 2013 revival update: 37 biotechs out, $2.8B raised from IPOs. More on the way. Feature | Follow @JohnCFierce

@DamianFierce: Merged at last on KKR's dime, PRA and RPS say they're the world's fourth-largest CRO. Article from FierceCRO | Follow @DamianFierce

@EmilyMFierce: $25M NIH project will set up genomic variants database for clinical use. More from FierceBiotech Research | Follow @EmilyMFierce

> Rise of personalized drugs means fewer 'dinosaur' trials. Item

> Merck KGaA amps up next-gen antibody pact with Ablynx. More

> Ispen joins crowd in Cambridge with R&D move. Article

Pharma News

@FiercePharma: Another plant gets warning letter. This time in PR, on repeat labeling probs. Article from FiercePharmaManufacturing | Follow @FiercePharma

> Merck gives up on unsuccessful Januvia combo drug. Article

> Merck KGaA overhauls pharma management to boost growth. Story

Pharma Manufacturing News

@EricPFierce: Kashmir-born Ph.D. picked by FDA to head office in India where problems mount. Story | Follow @EricPFierce

> Pfizer dumping plant, 140 workers in Australia. Item

> Sanofi building its largest African plant in Algeria. Report

> Purdue building $59M plant in North Carolina. More

> J&J says more Doxil shortages imminent, tied to Ben Venue problems. Story

> FDA warning points to infrastructure issue in India. Article

Vaccines News

> Merck KGaA lung cancer vaccine to re-enter Phase III. Item

> GSK, Merck and Pfizer join JP Morgan vaccine investment fund. Report

> European prices reapply old pressures to vaccine makers. Story

> Pandemic leads researchers to universal flu vaccine 'blueprint.' More

> U.K. gov makes U-turn on link between GSK vaccine and narcolepsy. Article